{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T10:06:52Z","timestamp":1746785212157},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T00:00:00Z","timestamp":1232668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s00393-008-0377-3","type":"journal-article","created":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T08:07:57Z","timestamp":1232525277000},"page":"124-131","source":"Crossref","is-referenced-by-count":10,"title":["Internistische und serologische Befunde der Riesenzellarteriitis"],"prefix":"10.1007","volume":"68","author":[{"given":"P.","family":"Vaith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Warnatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,23]]},"reference":[{"key":"377_CR1","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/art.23577","volume":"59","author":"Agard","year":"2008","unstructured":"Agard C, Barrier JH, Dupas B et al (2008) Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum 59:670\u2013676","journal-title":"Arthritis Rheum"},{"key":"377_CR2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0140-6736(93)90277-N","volume":"341","author":"Assicot","year":"1993","unstructured":"Assicot M, Gendrel D, Carsin H et al (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515\u2013518","journal-title":"Lancet"},{"key":"377_CR3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.38.5.434","volume":"38","author":"Bird","year":"1979","unstructured":"Bird HA, Esselinckx W, Dixon AS et al (1979) An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 38:434\u2013439","journal-title":"Ann Rheum Dis"},{"key":"377_CR4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/rheumatology\/kel376","volume":"46","author":"Blockmans","year":"2007","unstructured":"Blockmans D, De Ceuninck L, Vanderschueren S et al (2007) Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology 46:672\u2013677","journal-title":"Rheumatology"},{"key":"377_CR5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/art.21699","volume":"55","author":"Blockmans","year":"2006","unstructured":"Blockmans D, De Ceuninck L, Vanderschueren S et al (2006) Repetitive 18-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study in 35 patients. Arthritis Rheum 55:131\u2013137","journal-title":"Arthritis Rheum"},{"key":"377_CR6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/rheumatology\/ken119","volume":"47","author":"Blockmans","year":"2008","unstructured":"Blockmans D, Coudyzer W, Vanderschueren S et al (2008) Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology 47:1179\u20131184","journal-title":"Rheumatology"},{"key":"377_CR7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.bor.0000197996.04709.4e","volume":"18","author":"Bongartz","year":"2006","unstructured":"Bongartz T, Matteson EL (2006) Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol 18:10\u201317","journal-title":"Curr Opin Rheumatol"},{"key":"377_CR8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00002512-200825040-00002","volume":"25","author":"Cantini","year":"2008","unstructured":"Cantini F, Niccoli L, Nannini C et al (2008) Diagnosis and treatment of giant cell arteritis. Drugs Aging 25:281\u2013297","journal-title":"Drugs Aging"},{"key":"377_CR9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1212\/WNL.38.3.352","volume":"38","author":"Caselli","year":"1988","unstructured":"Caselli R, Hunder GG, Whisnant JP (1988) Neurologic diease in biopsy-proven giant cell (temporal) arteritis. Neurology 38:352\u2013359","journal-title":"Neurology"},{"key":"377_CR10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","volume":"97","author":"Chuang","year":"1982","unstructured":"Chuang TY, Hunder GG, Ilstrup DM, Kurland LT (1982) Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 97:672\u2013680","journal-title":"Ann Intern Med"},{"key":"377_CR11","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000030185.67510.C0","volume":"106","author":"Cid","year":"2002","unstructured":"Cid MC, Hernandez-Rodriguez J, Esteban MJ et al (2002) Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant-cell arteritis. Circulation 106:1664\u20131671","journal-title":"Circulation"},{"key":"377_CR12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/112067210401400310","volume":"14","author":"Costello","year":"2004","unstructured":"Costello F, Zimmerman MB, Podhajsky PA et al (2004) Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy. Eur J Ophthalmol 14:245\u2013257","journal-title":"Eur J Ophthalmol"},{"key":"377_CR13","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/1529-0131(199707)40:7<1250::AID-ART9>3.0.CO;2-A","volume":"40","author":"Eberhard","year":"1997","unstructured":"Eberhard OK, Haubitz M, Brunkhorst FM et al (1997) Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus\/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 40:1250\u20131256","journal-title":"Arthritis Rheum"},{"key":"377_CR14","doi-asserted-by":"crossref","unstructured":"Gonzalez-Gay MA, Lopez-Diaz MJ, Barros S et al (2005) Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. Medicine (Baltimore) 84:277\u2013290","DOI":"10.1097\/01.md.0000180043.19285.54"},{"key":"377_CR15","first-page":"171","volume":"19","author":"Hachulla","year":"2001","unstructured":"Hachulla E, Boivin V, Pasturel-Michon U et al (2001) Prognostic factors and long-term evolution in a cohort of 133 patients with giant cell arteritis. Clin Exp Rheumatol 19:171\u2013176","journal-title":"Clin Exp Rheumatol"},{"key":"377_CR16","first-page":"157","volume":"9","author":"Hachulla","year":"1991","unstructured":"Hachulla E, Saile R, Parra HJ et al (1991) Serum amyloid A concentrations in giant-cell arteritis and polymyalgia rheumatica: a useful test in the management of the disease. Clin Exp Rheumatol 9:157\u2013163","journal-title":"Clin Exp Rheumatol"},{"key":"377_CR17","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/art.20172","volume":"50","author":"Hellmann","year":"2004","unstructured":"Hellmann DB (2004) Low-dose aspirin in the treatment of giant cell arteritis. Arthritis Rheum 50:1026\u20131027","journal-title":"Arthritis Rheum"},{"key":"377_CR18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/art1.10161","volume":"47","author":"Hernandez-Rodriguez","year":"2002","unstructured":"Hernandez-Rodriguez J, Garcia-Martinez A, Casademont J et al (2002) A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis. Arthritis Rheum 47:29\u201335","journal-title":"Arthritis Rheum"},{"key":"377_CR19","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","volume":"33","author":"Hunder","year":"1990","unstructured":"Hunder GG, Bloch DA, Michel BA et al (1990) The American college of rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122\u20131128","journal-title":"Arthritis Rheum"},{"key":"377_CR20","doi-asserted-by":"crossref","first-page":"806","DOI":"10.7326\/0003-4819-83-6-806","volume":"83","author":"Klein","year":"1975","unstructured":"Klein RG, Hunder GG, Stanson AW, Sheps SG (1975) Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 83:806\u2013812","journal-title":"Ann Intern Med"},{"key":"377_CR21","doi-asserted-by":"crossref","first-page":"594","DOI":"10.7326\/0003-4819-101-5-594","volume":"101","author":"Larson","year":"1984","unstructured":"Larson TS, Hall S, Hepper NG, Hunder GG (1984) Respiratory tract symptoms as a clue to giant cell arteritis. Ann Intern Med 101:594\u2013597","journal-title":"Ann Intern Med"},{"key":"377_CR22","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/art.22754","volume":"56","author":"Mahr","year":"2007","unstructured":"Mahr AD, Jover JA, Spiera RF et al (2007) Adjunctive methotrexate for treatment of giant cell arteritis. An individual patient data meta-analysis. Arthritis Rheum 56:2789\u20132797","journal-title":"Arthritis Rheum"},{"key":"377_CR23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9343(97)89458-2","volume":"100","author":"Matteson","year":"1996","unstructured":"Matteson EL, Gold KN, Bloch DA, Hunder GG (1996) Long-term survival of patients with giant cell aretritis in the American college of rheumatology giant cell aretritis classification criteria cohort. Am J Med 100:193\u2013196","journal-title":"Am J Med"},{"key":"377_CR24","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/rheumatology\/35.11.1161","volume":"35","author":"Myklebust","year":"1996","unstructured":"Myklebust G, Gran JT (1996) A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 35:1161\u20131168","journal-title":"Br J Rheumatol"},{"key":"377_CR25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/rheumatology\/keg116","volume":"42","author":"Nordborg","year":"2003","unstructured":"Nordborg E, Nordborg C (2003) Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment. Rheumatology 42:413\u2013421","journal-title":"Rheumatology"},{"key":"377_CR26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/bmj.299.6698.549","volume":"299","author":"Nordborg","year":"1989","unstructured":"Nordborg E, Bengtssson BA (1989) Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. Br Med J 299:549\u2013540","journal-title":"Br Med J"},{"key":"377_CR27","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/art.11353","volume":"48","author":"Nuenninghoff","year":"2003","unstructured":"Nuenninghoff DM, Hunder GG, Christianson TJH et al (2003) Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection and\/or large artery stenosis) in patients with giant cell arteritis. A population-based study over 50 years. Arthritis Rheum 48:3522\u20133531","journal-title":"Arthritis Rheum"},{"key":"377_CR28","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1002\/art.11480","volume":"48","author":"Nuenninghoff","year":"2003","unstructured":"Nuenninghoff DM, Hunder GG, Christianson TJH et al (2003) Mortality of large-artery complication (aortic aneurysm, aortic dissection and\/or large artery stenosis) in patients with giant cell arteritis. Arthritis Rheum 48:3532\u20133537","journal-title":"Arthritis Rheum"},{"key":"377_CR29","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.ophtha.2006.05.020","volume":"113","author":"Parikh","year":"2006","unstructured":"Parikh M, Miller NR, Lee AG et al (2006) Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology 113:1842\u20131845","journal-title":"Ophthalmology"},{"key":"377_CR30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/BOR.0b013e3282f31769","volume":"20","author":"Pipitone","year":"2008","unstructured":"Pipitone N, Salvarani C (2008) Improving therapeutic options for patients with giant cell arteritis. Curr Opin Rheumatol 20:17\u201322","journal-title":"Curr Opin Rheumatol"},{"key":"377_CR31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/rheumatology\/37.7.797","volume":"37","author":"Pountain","year":"1998","unstructured":"Pountain G, Hazleman B, Cawston TE (1998) Circulating levels of IL-1beta, IL-6 and soluble IL-2 receptor in polymyalgia rheumatica and giant cell arteritis and rheumatoid arthritis. Br J Rheumatol 37:797\u2013798","journal-title":"Br J Rheumatol"},{"key":"377_CR32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/rheumatology\/33.6.550","volume":"33","author":"Pountain","year":"1994","unstructured":"Pountain GD, Calvin J, Hazleman BL (1994) Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 33:550\u2013554","journal-title":"Br J Rheumatol"},{"key":"377_CR33","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.11388","volume":"49","author":"Proven","year":"2003","unstructured":"Proven A, Gabriel SE, Orces C et al (2003) Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum 49:703\u2013708","journal-title":"Arthritis Rheum"},{"key":"377_CR34","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/rheumatology\/39.12.1396","volume":"39","author":"Reinhold-Keller","year":"2000","unstructured":"Reinhold-Keller E, Zeidler A, Gutfleisch J et al (2000) Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany. Rheumatology 39:1396\u20131402","journal-title":"Rheumatology"},{"key":"377_CR35","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/art.1780360913","volume":"36","author":"Roche","year":"1993","unstructured":"Roche NE, Fulbright JW, Wagner AD et al (1993) Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 36:1286\u20131294","journal-title":"Arthritis Rheum"},{"key":"377_CR36","first-page":"S23","volume":"21","author":"Salvarani","year":"2003","unstructured":"Salvarani C, Cantini F, Boiardi L et al (2003) Laboratory investigations useful in giant cell arteritis and Takayasu\u2019s arteritis. Clin Exp Rheumatol 21:S23\u2013S28","journal-title":"Clin Exp Rheumatol"},{"key":"377_CR37","first-page":"1100","volume":"19","author":"Salvarani","year":"1992","unstructured":"Salvarani C, Macchioni P, Boiardi L et al (1992) Soluble interleukin 2 receptors in polymyalgia rheumatica\/giant cell arteritis. Clinical and laboratory correlations. J Rheumatol 19:1100\u20131106","journal-title":"J Rheumatol"},{"key":"377_CR38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","volume":"347","author":"Salvarani","year":"2002","unstructured":"Salvarani C, Cantini F, Boiardi L, Hunder GG (2002) Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 347:261\u2013271","journal-title":"N Engl J Med"},{"key":"377_CR39","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","volume":"372","author":"Salvarani","year":"2008","unstructured":"Salvarani C, Cantini F, Hunder GG (2008) Polymyalgia rheumatica and giant-cell arteritis. Lancet 372:234\u2013245","journal-title":"Lancet"},{"key":"377_CR40","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/ard.2007.084723","volume":"67","author":"Salvarani","year":"2008","unstructured":"Salvarani C, Barozzi L, Cantini F et al (2008) Cervical interspinous bursitis in active polymyalgia rheumatica. Ann Rheum Dis 67:758\u2013761","journal-title":"Ann Rheum Dis"},{"key":"377_CR41","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1055\/s-2005-871912","volume":"130","author":"Schmidt","year":"2005","unstructured":"Schmidt D, Vaith P (2005) Riesenzellarteriitis (Arteriitis cranialis, Arteriitis temporalis Horton). Dtsch Med Wochenschr 130:1877\u20131881","journal-title":"Dtsch Med Wochenschr"},{"key":"377_CR42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jama.287.1.92","volume":"287","author":"Smetana","year":"2002","unstructured":"Smetana GW, Shmerling RH (2002) Does this patient have temporal arteritis? JAMA 287:92\u2013101","journal-title":"JAMA"},{"key":"377_CR43","unstructured":"Vaith P (1997) Polymyalgia rheumatica und Riesenzellarteriitis. In: Peter HH (Hrsg) Klinik der Gegenwart, Bd 4: XIV. Urban & Schwarzenberg, M\u00fcnchen Wien Baltimore, S 1\u201319"},{"key":"377_CR44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000237354","volume":"111","author":"Vaith","year":"1996","unstructured":"Vaith P, Prasauskas V, Potempa LA et al (1996) Complement activation by C-reactive protein on the HEp-2 cell substrate. Int Arch Allergy Immunol 111:107\u2013117","journal-title":"Int Arch Allergy Immunol"},{"key":"377_CR45","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/03009747609099905","volume":"5","author":"KJ","year":"1976","unstructured":"KJ von, Wassatjerna C (1976) Liver involvement in polymyalgia rheumatica. Scand J Rheumatol 5:197\u2013204","journal-title":"Scand J Rheumatol"},{"key":"377_CR46","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/1529-0131(200005)43:5<1041::AID-ANR12>3.0.CO;2-7","volume":"43","author":"Weyand","year":"2000","unstructured":"Weyand CM, Fulbright JW, Hunder GG et al (2000) Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity. Arthritis Rheum 43:1041\u20131048","journal-title":"Arthritis Rheum"},{"key":"377_CR47","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMra022694","volume":"349","author":"Weyand","year":"2003","unstructured":"Weyand CM, Goronzy JJ (2003) Medium- and large-vessel vasculitis. N Engl J Med 349:160\u2013169","journal-title":"N Engl J Med"},{"key":"377_CR48","unstructured":"Reinhard M, Schmidt WA, Hetzel A, Bley TA (2008) Bildgebung der Riesenzellarteriitis mittels Sonographie und MRT. Z Rheumatol (DOI: s00393-008-0375-5)"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-008-0377-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-008-0377-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-008-0377-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:35:57Z","timestamp":1559061357000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-008-0377-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,23]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["377"],"URL":"https:\/\/doi.org\/10.1007\/s00393-008-0377-3","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,23]]}}}